W. Tremaine, L. Melton, P. Munkholm, and W. Sandborn, Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county

J. Eaden, K. Abrams, and J. Mayberry, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, vol.48, issue.4, pp.526-561, 2001.
DOI : 10.1136/gut.48.4.526

M. Rutter, B. Saunders, K. Wilkinson, S. Rumbles, G. Schofield et al., Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis, Gastroenterology, vol.130, issue.4, pp.1030-1038, 2006.
DOI : 10.1053/j.gastro.2005.12.035

T. Jess, C. Rungoe, and L. Peyrin-biroulet, Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6, pp.639-684, 2012.
DOI : 10.1016/j.cgh.2012.01.010

H. Tilg, S. Travis, and J. Lindsay, Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations J Crohns Colitis, 2012.

M. Claessen, F. Vleggaar, K. Tytgat, P. Siersema, and H. Van-buuren, High lifetime risk of cancer in primary sclerosing cholangitis, Journal of Hepatology, vol.50, issue.1, pp.158-64, 2009.
DOI : 10.1016/j.jhep.2008.08.013

M. Rutter, B. Saunders, K. Wilkinson, S. Rumbles, G. Schofield et al., Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, vol.126, issue.2, pp.451-460, 2004.
DOI : 10.1053/j.gastro.2003.11.010

K. Nuako, D. Ahlquist, D. Mahoney, D. Schaid, D. Siems et al., Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study, Gastroenterology, vol.115, issue.5
DOI : 10.1016/S0016-5085(98)70077-0

W. Sandborn, Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case ?control study, Gastroenterology, vol.130, pp.1941-1950, 2006.

F. Valeyos, J. Terdiman, and J. Walsh, Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-53, 2005.
DOI : 10.1097/00054725-200401000-00003

G. Nguyen, A. Gulamhusein, and C. Bernstein, 5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations, The American Journal of Gastroenterology, vol.107, issue.9, pp.1298-304, 2012.
DOI : 10.1053/j.gastro.2010.02.007

D. Pardi, L. Jr, E. Kremers, W. Keach, J. Lindor et al., Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis, Gastroenterology, vol.124, issue.4
DOI : 10.1053/gast.2003.50156

L. Peyrin-biroulet, K. Khosrotehrani, F. Carrat, A. Bouvier, J. Chevaux et al., Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease, Gastroenterology, vol.141, issue.5, pp.1621-1629, 2011.
DOI : 10.1053/j.gastro.2011.06.050

URL : https://hal.archives-ouvertes.fr/hal-00631539

L. Peyrin-biroulet, C. Lepage, V. Jooste, J. Guéant, J. Faivre et al., Colorectal cancer in inflammatory bowel diseases: A population-based study, Inflamm Bowel Dis, vol.18, pp.2241-51, 1976.

C. Bernstein, F. Shanahan, and W. Weinstein, Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis, Lancet, vol.343, pp.71-75, 1994.

T. Ullman, V. Croog, N. Harpaz, D. Sachar, and S. Itzkowitz, Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis, Gastroenterology, vol.125, issue.5, pp.1311-1320, 2003.
DOI : 10.1016/j.gastro.2003.08.023

T. Thomas, K. Abrams, R. Robinson, and J. Mayberry, Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis, Alimentary Pharmacology & Therapeutics, vol.43, issue.2, pp.657-68, 2007.
DOI : 10.1016/0016-5085(92)91163-X

T. Jess, M. Gamborg, P. Matzen, P. Munkholm, and T. Sørensen, Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2733, 2005.
DOI : 10.1111/j.1572-0241.2003.08671.x

T. Ullman, T. James, R. Mcleod, L. Burgart, A. J. Brill et al., AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease, Gastroenterology, vol.138, pp.738-783, 2010.

B. Vucelic and E. Stange, European Crohn's and Colitis Organisation (ECCO) European evidence-based Consensus on the management of ulcerative colitis: Special situations, J

L. Peyrin-biroulet, A. Oussalah, N. Williet, C. Pillot, L. Bresler et al., Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011.
DOI : 10.1136/gut.2010.227884

D. Drossman, J. Leserman, Z. Li, C. Mitchell, E. Zagami et al., The rating form of IBD patient concerns: a new measure of health status., Psychosomatic Medicine, vol.53, issue.6, pp.701-713, 1991.
DOI : 10.1097/00006842-199111000-00010

R. Robinson, A. Hart, and J. Mayberry, Cancer Surveillance in Ulcerative Colitis: A Survey of Patients' Knowledge, Endoscopy, vol.28, issue.09, pp.761-763, 1996.
DOI : 10.1055/s-2007-1005601

K. Emmons, Screening patients with a family history of colorectal cancer, J Gen Intern Med, vol.22, pp.508-521, 2007.

B. Kl, S. Promislow, R. Carr, P. Rawsthorne, J. Walker et al., Information needs and preferences of recently diagnosed patients with inflammatory bowel disease

P. Politi, P. Bodini, M. Mortilla, M. Beltrami, G. Fornaciari et al., Communication of information to patients with inflammatory bowel disease: A European Collaborative Study in a multinational prospective inception cohort, Journal of Crohn's and Colitis, vol.94, issue.Suppl, pp.226-258, 2008.
DOI : 10.1111/j.1572-0241.1999.01536.x

A. Bernard, M. Langille, S. Hughes, C. Rose, D. Leddin et al., A Systematic Review of Patient Inflammatory Bowel Disease Information Resources on the World Wide Web, The American Journal of Gastroenterology, vol.72, issue.9, pp.2070-2077, 2007.
DOI : 10.1016/S0022-5347(05)00996-1

S. Van-der-marel, M. Duijvestein, J. Hardwick, G. Van-den-brink, R. Veenendaal et al., Quality of web-based information on inflammatory bowel diseases, Inflammatory Bowel Diseases, vol.102, issue.12, pp.1891-1897, 2009.
DOI : 10.1111/j.1572-0241.2007.01325.x

J. Eaden, B. Ward, and J. Mayberry, How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance, Gastrointestinal Endoscopy, vol.51, issue.2, pp.123-131, 2000.
DOI : 10.1016/S0016-5107(00)70405-6

A. Van-rijn, P. Fockens, P. Siersema, and B. Oldenburg, Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn???s colitis patients in the Netherlands, World Journal of Gastroenterology, vol.15, issue.2, pp.226-256, 2009.
DOI : 10.3748/wjg.15.226

J. Panés, Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, vol.17, pp.1759-68, 2011.

V. Fazio, Y. Ziv, and J. Church, IIeal Pouch-Anal Anastomoses Complications and Function in 1005 Patients, Annals of Surgery, vol.222, issue.2, pp.120-127, 1995.
DOI : 10.1097/00000658-199508000-00003

S. Kane, R. Cohen, J. Aikens, and S. Hanauer, Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis, The American Journal of Gastroenterology, vol.8, issue.10, pp.2929-2962, 2001.
DOI : 10.1046/j.1365-2036.2000.00698.x

E. Loftus, . Jr, P. Schoenfeld, and W. Sandborn, The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review, Alimentary Pharmacology and Therapeutics, vol.133, issue.1
DOI : 10.1016/S0022-3476(98)70187-8

T. Jess, E. Loftus, . Jr, and F. Velayos, REFERENCES 1 Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Aliment Pharmacol Ther Minnesota. Gastoenterology, vol.16130, pp.51-601039, 2002.

T. Jess, C. Rungoe, and L. Peyrin-biroulet, Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies, Clinical Gastroenterology and Hepatology, vol.10, issue.6, pp.639-645, 2012.
DOI : 10.1016/j.cgh.2012.01.010

L. Biancone, P. Michetti, and S. Travis, European evidence-based Consensus on the management of ulcerative colitis: Special situations, Journal of Crohn's and Colitis, vol.23, issue.Suppl II, pp.63-92, 2008.
DOI : 10.1111/j.1365-2036.2006.02761.x

F. Valeyos, J. Terdiman, and J. Walsh, Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies, The American Journal of Gastroenterology, vol.18, issue.2, pp.1345-1353, 2005.
DOI : 10.1097/00054725-200401000-00003

G. Nguyen, A. Gulamhusein, and C. Bernstein, 5-aminosalicylic Acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations

T. Jess, M. Gamborg, and P. Matzen, Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2729, 2005.
DOI : 10.1111/j.1572-0241.2003.08671.x

L. Peyrin-biroulet, C. Lepage, and V. Jooste, Colorectal cancer in inflammatory bowel diseases: A population-based study Inflamm Bowel Dis, 1976.